Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI

Zentralblatt fur Gynakologie

Volumn 119, Issue 1, 1997, Pages 6-11

  Sommer, H ^a,b   Tiling, R ^a   Pechmann, Martina ^a   Kindermann, G ^a   Kress, Katharina ^a   Moser, Ruth ^a   Tatsch, K ^a   Hahn, K ^a   Pfluger, T ^a   Assemi, C ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

breast cancer; contrast enhanced MRI; multidrug resistance; semiquantitative scintimammography; Tc 99m sestamibi

Indexed keywords

CONTRAST MEDIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; BREAST CANCER; BREAST LESION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTIGRAPHY;

AGED; AGED, 80 AND OVER; BIOPSY; BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROCYSTIC BREAST DISEASE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 8044259635     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Berg JW, Hutter RV: Breast cancer. Cancer 75 (1995) 257-269
2. Bird RE, Wallace TW, Yankanskas BC: Analysis of cancer missed at the screening mammography. Radiology 184 (1992) 613-617
3. Burak Z, Argon M, Memis A, et al.: Evaluation of palpable breast masses with 99m Tc-MIBI: A comparative study with mammography and ultrasonography. Nucl Med Comm 15 (1994) 604-612
4. Giller R, Guinebretiere JM, Lucidarme O, et al.: Non-palpable breast tumors: Diagnosis with contrast enhanced subtraction dynamic MR imaging. Radiology 191 (1994) 625-631
5. Heywang-Köbrunner SH: Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 29 (1994) 94-104
6. Jackson VP, Hendrick RE, Kerg SA, et al.: Imaging of the radiographically dense breast. Radiology 198 (1993) 297-301
7. Kao CH, Wang SJ, Liu TJ: The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 21 (1994) 432-436
8. Khalkhali. I, Mena I, Diggles L: Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technitium-99m sestamibi. Eur J Nucl Med 21 (1994) 357-362
9. Khalkhali I, Cutrone J, Mena I, et al.: The usefulness of scintimammography in patients with dense breast on mammogram (abstract). J Nucl Med 36 (1995) 52
10. Orel SG, Schnall MD, Livolsi VA, Troupin RH: Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 190 (1994) 485-493
11. Palmedo H, Schomburg A, Grünwald F, Bender H, Mallmann P, Biersack HJ: Mammoscintigraphy with Tc-99m MIBI: Planar and SPECT imaging techniques in patients with suspicious breast nodules (abstract). J Nucl Med 36 (1995) 51-52
12. Piwnica-Worms D, Chiu ML, Budding M: Functional Imaging of Multidrug-resistant P-Glycoprotein with an Organotechnetium Complex, Cancer Research 53 (1993) 977-984
13. Tiling R, Sommer H, Pechmann M, et al.: Detection of carcinomas in mammographic dense breast and mastopathies: Gd-enhanced MRI versus semiquantitative Tc-99m sestamibi (abstract). Eur J Nucl Med 22 (1995) 726